Your browser doesn't support javascript.
loading
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children.
Cunningham, Coleen K; Karron, Ruth A; Muresan, Petronella; Kelly, Matthew S; McFarland, Elizabeth J; Perlowski, Charlotte; Libous, Jennifer; Oliva, Jennifer; Jean-Philippe, Patrick; Moye, Jack; Schappell, Elizabeth; Barr, Emily; Rexroad, Vivian; Johnston, Benjamin; Chadwick, Ellen G; Cielo, Mikhaela; Paul, Mary; Deville, Jaime G; Aziz, Mariam; Yang, Lijuan; Luongo, Cindy; Collins, Peter L; Buchholz, Ursula J.
Afiliación
  • Cunningham CK; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
  • Karron RA; Department of Pediatrics, University of California, Irvine, California, USA.
  • Muresan P; Children's Hospital of Orange County, Orange, California, USA.
  • Kelly MS; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • McFarland EJ; Statistical and Data Management Center/Frontier Science and Technology Research Foundation, Brookline, Massachusetts, USA.
  • Perlowski C; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
  • Libous J; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Oliva J; FHI 360, Durham, North Carolina, USA.
  • Jean-Philippe P; FHI 360, Durham, North Carolina, USA.
  • Moye J; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Schappell E; Maternal, Adolescent and Pediatric Research Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Barr E; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
  • Rexroad V; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Johnston B; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Chadwick EG; Investigational Drug Service Pharmacy, Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Cielo M; Frontier Science and Technology Research Foundation, Buffalo, New York, USA.
  • Paul M; Department of Pediatrics, Northwestern University Feinberg School of Medicine and Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Deville JG; Division of Infectious Diseases, Maternal Child and Adolescent Center, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Aziz M; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Yang L; David Geffen School of Medicine at University of California, Los Angeles, California, USA.
  • Luongo C; Rush University Medical Center, Cook County Hospital, Chicago, Illinois, USA.
  • Collins PL; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Buchholz UJ; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
J Infect Dis ; 226(12): 2069-2078, 2022 12 13.
Article en En | MEDLINE | ID: mdl-35732186
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Child / Humans Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Child / Humans Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos